CO4980891A1 - Asociacion de principios activos para el tratamiento de la demencia senil de tipo azheimer - Google Patents

Asociacion de principios activos para el tratamiento de la demencia senil de tipo azheimer

Info

Publication number
CO4980891A1
CO4980891A1 CO98062479A CO98062479A CO4980891A1 CO 4980891 A1 CO4980891 A1 CO 4980891A1 CO 98062479 A CO98062479 A CO 98062479A CO 98062479 A CO98062479 A CO 98062479A CO 4980891 A1 CO4980891 A1 CO 4980891A1
Authority
CO
Colombia
Prior art keywords
alkyl
halogen
alkoxy
group
alkoxycarbonyl
Prior art date
Application number
CO98062479A
Other languages
English (en)
Spanish (es)
Inventor
Jean Pierre Maffrand
Philippe Soubrie
Terranova Jean Paul
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9714324A external-priority patent/FR2771006B1/fr
Priority claimed from FR9714322A external-priority patent/FR2771007B1/fr
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of CO4980891A1 publication Critical patent/CO4980891A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
CO98062479A 1997-11-14 1998-10-26 Asociacion de principios activos para el tratamiento de la demencia senil de tipo azheimer CO4980891A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9714324A FR2771006B1 (fr) 1997-11-14 1997-11-14 Association de principes actifs pour le traitement de la demence senile du type alzheimer
FR9714322A FR2771007B1 (fr) 1997-11-14 1997-11-14 Association de principes actifs pour le traitement de la demence senile du type alzheimer

Publications (1)

Publication Number Publication Date
CO4980891A1 true CO4980891A1 (es) 2000-11-27

Family

ID=26233932

Family Applications (1)

Application Number Title Priority Date Filing Date
CO98062479A CO4980891A1 (es) 1997-11-14 1998-10-26 Asociacion de principios activos para el tratamiento de la demencia senil de tipo azheimer

Country Status (27)

Country Link
EP (1) EP1030671A1 (ko)
JP (1) JP2001523642A (ko)
KR (1) KR100599350B1 (ko)
CN (1) CN1243540C (ko)
AU (1) AU743228B2 (ko)
BG (1) BG64819B1 (ko)
BR (1) BR9814035A (ko)
CA (1) CA2309966A1 (ko)
CO (1) CO4980891A1 (ko)
DZ (1) DZ2649A1 (ko)
EA (1) EA003255B1 (ko)
EE (1) EE04235B1 (ko)
HU (1) HUP0100098A3 (ko)
ID (1) ID24933A (ko)
IL (2) IL136122A0 (ko)
IS (1) IS5482A (ko)
MY (1) MY120461A (ko)
NO (1) NO20002450L (ko)
NZ (1) NZ504420A (ko)
OA (1) OA11464A (ko)
PL (1) PL194597B1 (ko)
SA (1) SA98190747B1 (ko)
SK (1) SK286040B6 (ko)
TR (1) TR200001262T2 (ko)
TW (1) TW585766B (ko)
UY (1) UY25247A1 (ko)
WO (1) WO1999025363A1 (ko)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2389937T3 (en) * 2002-06-14 2018-11-12 Toyama Chemical Co Ltd Medical composition to improve brain function
PT1529116E (pt) * 2002-08-07 2009-09-10 Novartis Ag Métodos para o tratamento da demência com base no genótipo da apo e
CN1520818A (zh) * 2003-02-09 2004-08-18 山东绿叶天然药物研究开发有限公司 治疗老年性痴呆的胆碱酯酶抑制剂药物组合物
US8481565B2 (en) 2004-12-27 2013-07-09 Eisai R&D Management Co., Ltd. Method for stabilizing anti-dementia drug
ES2721001T3 (es) 2014-01-31 2019-07-26 Cognition Therapeutics Inc Derivado de isoindolina, y composiciones y métodos para tratar una enfermedad neurodegenerativa
EP3634394A4 (en) 2017-05-15 2021-04-07 Cognition Therapeutics, Inc. COMPOSITIONS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES
KR102224918B1 (ko) 2018-03-20 2021-03-09 (주)인벤티지랩 도네페질 및 메만틴을 포함하는 인지 장애 관련 질병의 예방 또는 치료용 약학적 복합 조성물 및 이의 제조 방법
WO2019182319A1 (ko) * 2018-03-20 2019-09-26 (주)인벤티지랩 인지 장애 관련 질병의 예방 또는 치료용 약학적 조성물의 제조 방법 및 이의 제조 방법으로 제조된 인지 장애 관련 질병의 예방 또는 치료용 약학적 조성물
CN109265391B (zh) * 2018-11-13 2021-11-19 枣庄学院 联苯多取代1,2,5,6-四氢吡啶化合物及其合成方法与应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2662355B1 (fr) * 1990-05-22 1994-11-10 Sanofi Sa Utilisation de la 1-[2-(2-naphtyl)ethyl]-4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine pour la preparation de medicaments destines au traitement de troubles cerebraux et neuronaux.
US5453428A (en) * 1991-02-14 1995-09-26 The Mount Sinai School Of Medicine Of The City Of New York Method and composition for the treatment of apathy-amotivation syndrome
ES2244968T3 (es) * 1995-03-06 2005-12-16 Interneuron Pharmaceuticals Incorporated Reduccion del volumen de infarto usando citocolina.
FR2736053B1 (fr) * 1995-06-28 1997-09-19 Sanofi Sa Nouvelles 1-phenylalkyl-1,2,3,6-tetrahydropyridines

Also Published As

Publication number Publication date
DZ2649A1 (fr) 2004-12-28
HUP0100098A2 (hu) 2001-07-30
KR100599350B1 (ko) 2006-07-12
EE04235B1 (et) 2004-02-16
TW585766B (en) 2004-05-01
NO20002450L (no) 2000-07-14
IS5482A (is) 2000-05-09
SA98190747B1 (ar) 2006-11-04
TR200001262T2 (tr) 2001-01-22
KR20010032099A (ko) 2001-04-16
CN1243540C (zh) 2006-03-01
NO20002450D0 (no) 2000-05-11
HUP0100098A3 (en) 2001-12-28
IL136122A (en) 2006-07-05
MY120461A (en) 2005-10-31
PL340500A1 (en) 2001-02-12
CA2309966A1 (en) 1999-05-27
EP1030671A1 (fr) 2000-08-30
BG104428A (en) 2001-08-31
SK286040B6 (sk) 2008-01-07
BR9814035A (pt) 2000-09-26
CN1285742A (zh) 2001-02-28
EA200000412A1 (ru) 2000-12-25
PL194597B1 (pl) 2007-06-29
SK7112000A3 (en) 2000-10-09
AU743228B2 (en) 2002-01-24
EA003255B1 (ru) 2003-02-27
WO1999025363A1 (fr) 1999-05-27
AU1160999A (en) 1999-06-07
EE200000290A (et) 2001-06-15
ID24933A (id) 2000-08-31
NZ504420A (en) 2003-08-29
BG64819B1 (bg) 2006-05-31
IL136122A0 (en) 2001-05-20
OA11464A (en) 2003-11-18
JP2001523642A (ja) 2001-11-27
UY25247A1 (es) 2001-05-31

Similar Documents

Publication Publication Date Title
CO4980891A1 (es) Asociacion de principios activos para el tratamiento de la demencia senil de tipo azheimer
CA2225746A1 (en) 4-aryl-1-phenylalkyl-1,2,3,6-tetrahydropyridines having neurotrophic and neuroprotective activity
HUT60733A (en) Process for producing new n-(4-piperidinyl)-(dihydrobenzofuran or dihydro-2h-benzopyran)-carboxamide derivatives and pharmaceutical compositions comprising such compounds
TR199801211T2 (xx) Takikinin resept�r antagonistleri olarak 1-(1,2-�ift-ikameli piperidinil ) -4-ikameli piperidin t�revleri.
AP2002002407A0 (en) Caspase inhibitors and uses thereof.
NO990551L (no) Piperidin- og piperazinderivater, og deres anvendelse som muskarine antagonister
JP2003506406A5 (ko)
EA018268B1 (ru) Аналоги пиридона и пиридазона как модуляторы gpr119
AU2003278296A1 (en) Piperidine quinolyl propyl derivatives, preparation method and intermediates and compositions containing same
CA2288241A1 (en) Use of tetrahydropyridine derivatives to prepare medicines for treating diseases causing demyelination
MY121852A (en) 4-(aminoethyl)-piperidine benzamides for treating gastrointestinal disorders
EA200600829A1 (ru) Новые кристаллические формы {2-[1-(3,5-бистрифторметилбензил)-5-пиридин-4-ил-1н-[1,2,3]триазол-4-ил]-пиридин-3-ил}-(2-хлорфенил)метанона
JP2001523642A5 (ko)
MX9708612A (es) Derivados de alfa-(alquilfenilo sustituido)-4-(hidroxidifenilmetil)-1-piperidinbutanol, su preparacion y su uso como antihistaminas, agentes antialergicos, y broncodilatadores.
FR2757160B1 (fr) 1-phenylalkyl-1,2,3,6-tetrahydropyridines
AR013750A1 (es) Asociacion de principios activos para el tratamiento de la demencia senil de tipo alzheimer
RU2003123119A (ru) Модуляторы натриевых каналов, являющиеся производными 2-пиперидилимидазолов
AR003905A1 (es) Compuestos inhibidores pirazinona de trombina y sus sales, procedimiento para la preparacion de sales, composiciones de las mismas, metodos paratratamientos y uso del compuesto para la manufactura de medicamentos.